Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Nonacog Beta Pegol for Prophylactic Treatment of Children with Hemophilia B: Up to 3.5-Year Data from the Paradigm™5 Clinical Trial

Susan Kearney, MD, Elena Santagostino, Manuel Carcao, MD, Faraizah Abdul Karim, MD, Masashi Taki, MD PhD, Meng Yao Lu, MD, May-Lill Garly, MD PhD, Marek Zak, MD PhD

Blood (2017) 130 (Supplement 1): 1092.

https://doi.org/10.1182/blood.V130.Suppl_1.1092.1092

Published: 2017

Journal Articles

Genotype/Phenotype Correlations in 103 Children from 87 Families with Hereditary Spherocytosis

Jakob Pugi, BSc, Luke J. Drury, PhDBS, Jacob C. Langer, MD FRCSC, Sheila Butchart, BScN, RN, Michelle Fantauzzi, BScN, RN, Jillian Baker, MD MSc, Victor S. Blanchette, FRCP, FRCPC, Melanie Ann Kirby-Allen, MD FRCPC, MBBS, Manuel Carcao, MD

Blood (2016) 128 (22): 2432.

https://doi.org/10.1182/blood.V128.22.2432.2432

Published: 2016

Journal Articles

a Randomized, Double-Blinded, Placebo Controlled Study of IVIG Vs. IVIG with High Dose Methylprednisolone in Rapidly Augmenting Platelet Counts in Childhood ITP

Manuel Carcao, MD, Mariana Silva, MD FRCPC, Michele David, MD FRCPC, Robert J. Klaassen, MD FRCP, MacGregor Steele, MD FRCP(C), Victoria E. Price, MBChB, MD, Cindy Wakefield, Derek Stephens, MSc, Victor S. Blanchette, MD FRCPC

Blood (2016) 128 (22): 868.

https://doi.org/10.1182/blood.V128.22.868.868

Published: 2016

Journal Articles

Risk Factors for the Development of High-Titer Inhibitors in 260 Children with Severe Hemophilia a Born Between 1990 and 2009: The Remain Study

Blood (2016) 128 (22): 3774.

https://doi.org/10.1182/blood.V128.22.3774.3774

Published: 2016

Journal Articles

Inhibitor Development in Previously Untreated Patients with Severe Hemophilia a Treated with Nuwiq ® , a New Generation Recombinant FVIII of Human Origin

Blood (2016) 128 (22): 327.

https://doi.org/10.1182/blood.V128.22.327.327

Published: 2016

Journal Articles

Hemophilia Prophylaxis No Longer Just for Children without Inhibitors - Increasing Use of Prophylaxis in Other Groups (children with inhibitors and adults with and without inhibitors)

Manuel Carcao, MD, Maria L. Avila, MD, Victor S. Blanchette, MD FRCP, Elena Santagostino, MD PhD, Carmen Escuriola-Ettingshausen, MD PhD, Cindy A. Leissinger, MD, Thierry Lambert, Louis M. Aledort, MD

Blood (2015) 126 (23): 3535.

https://doi.org/10.1182/blood.V126.23.3535.3535

Published: 2015

Journal Articles

Safety, Efficacy and Pharmacokinetics of Nonacog Beta Pegol (N9-GP) in Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Pediatric Hemophilia B Patients

Manuel Carcao, MD MSc, Marek Zak, Fara Abdul Karim, Hideji Hanabusa, MD, Susan Kearney, Meng-Yao Lu, Paula Persson, Savita Rangarajan, Elena Santagostino, MD PhD

Blood (2014) 124 (21): 1513.

https://doi.org/10.1182/blood.V124.21.1513.1513

Published: 2014

Journal Articles

Clearance and Genetic Variability of Von Willebrand Factor Are Major Determinants of the Pharmacokinetic Behavior of Factor VIII Concentrates in the Treatment of Pediatric Hemophilia A

Kenichi Ogiwara, MD PhD, Laura L Swystun, PhD, Ilinca Georgescu, Christine Brown, Angie Tuttle, Shawn Tinlin, Jayne Leggo, Silvia Albánez, MSc, Manuel Carcao, MD MSc, Victor S. Blanchette, MD FRCPC, Christoph Male, MD MSC, Katharina Thom, David Lillicrap, MD

Blood (2014) 124 (21): 473.

https://doi.org/10.1182/blood.V124.21.473.473

Published: 2014

Journal Articles

Impact of Exercise on Hemostasis in Boys with Hemophilia a (HA) and B (HB): Principal Findings of the Sickkids Hemophilia Exercise Study

Riten Kumar, MD MSc, Vanessa Bouskill, MN, RN (EC), Walter H.A. Kahr, MD PhD, Allison Craik, Fred G Pluthero, Jane E Schneiderman, PhD, Dewi S. Clark, BSc, Kharen Whitney, Christine Zhang, Margaret L. Rand, PhD, Manuel Carcao, MD MSc

Blood (2014) 124 (21): 1493.

https://doi.org/10.1182/blood.V124.21.1493.1493

Published: 2014

Journal Articles

Pharmacokinetic Characterisation Of Recombinant FXIII Across Age Groups In Patients With FXIII Subunit A Congenital Deficiency

Brigitte Brand-Staufer, MD, Manuel Carção, MD, BSC, Bryce A. Kerlin, MD, Diane Nugent, MD, Andrew Will, Michael Williams, Anders Rosholm, MSc, PhD, Mia Sandberg Lundblad

Blood (2013) 122 (21): 3613.

https://doi.org/10.1182/blood.V122.21.3613.3613

Published: 2013

Journal Articles

Recombinant Factor XIII, Safe and Novel Treatment for Congenital Factor XIII Deficiency

Aida Inbal, MD, Johannes Oldenburg, MD, Manuel Carcao, MD, BSC, Anders Rosholm, MSc, PhD, Ramin Tehranchi, MD, PhD, Diane J Nugent, MD

Blood (2010) 116 (21): 20.

https://doi.org/10.1182/blood.V116.21.20.20

Published: 2010

Journal Articles

The Care of Immigrant Children with Haemophilia.

Chris Barnes, MB BS, Pam Hilliard, BSc(PT), Ann Marie Stain, RN, Georgina Floros, RN, Victor Blanchette, MD, Manuel Carcao, MD

Blood (2004) 104 (11): 4013.

https://doi.org/10.1182/blood.V104.11.4013.4013

Published: 2004

Journal Articles

Novel and Clinically Significant Factors Influencing the Pharmacokinetic Variability of Recombinant Factor VIII (Kogenate-FS) in Children.

Chris Barnes, MB, BS, David Lillicrap, MD, Victor Blanchette, MD, Ann Marie Stain, RN, Janneth Pazmino-Canizares, MSc, Dewi Clark, Bsc, Caroline Hensmen, MLT, Manuel Carcao, MD

Blood (2004) 104 (11): 3991.

https://doi.org/10.1182/blood.V104.11.3991.3991

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Nonacog Beta Pegol for Prophylactic Treatment of Children with Hemophilia B: Up to 3.5-Year Data from the Paradigm™5 Clinical Trial

Genotype/Phenotype Correlations in 103 Children from 87 Families with Hereditary Spherocytosis

a Randomized, Double-Blinded, Placebo Controlled Study of IVIG Vs. IVIG with High Dose Methylprednisolone in Rapidly Augmenting Platelet Counts in Childhood ITP

Risk Factors for the Development of High-Titer Inhibitors in 260 Children with Severe Hemophilia a Born Between 1990 and 2009: The Remain Study

Inhibitor Development in Previously Untreated Patients with Severe Hemophilia a Treated with Nuwiq ® , a New Generation Recombinant FVIII of Human Origin

Hemophilia Prophylaxis No Longer Just for Children without Inhibitors - Increasing Use of Prophylaxis in Other Groups (children with inhibitors and adults with and without inhibitors)

Safety, Efficacy and Pharmacokinetics of Nonacog Beta Pegol (N9-GP) in Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Pediatric Hemophilia B Patients

Clearance and Genetic Variability of Von Willebrand Factor Are Major Determinants of the Pharmacokinetic Behavior of Factor VIII Concentrates in the Treatment of Pediatric Hemophilia A

Impact of Exercise on Hemostasis in Boys with Hemophilia a (HA) and B (HB): Principal Findings of the Sickkids Hemophilia Exercise Study

Pharmacokinetic Characterisation Of Recombinant FXIII Across Age Groups In Patients With FXIII Subunit A Congenital Deficiency

Recombinant Factor XIII, Safe and Novel Treatment for Congenital Factor XIII Deficiency

The Care of Immigrant Children with Haemophilia.

Novel and Clinically Significant Factors Influencing the Pharmacokinetic Variability of Recombinant Factor VIII (Kogenate-FS) in Children.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only